Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Current Deferred Revenue (2009 - 2026)

Compugen (CGEN) posted quarterly Current Deferred Revenue of $11.6 million for Q1 2026, up 20.49% year-over-year from $9.6 million in Q1 2025, and up 5.72% on a QoQ basis from $11.0 million in Q4 2025.

Analysis

Compugen (CGEN) Current Deferred Revenue (2009 - 2026) Analysis & Trends

Compugen has reported Current Deferred Revenue for 10 years, with the latest figure at $11.6 million in Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $11.6 million, up 20.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (up 20.49% YoY), and the FY2025 annual result was $11.0 million, up 13.89% from the prior year.
  • Current Deferred Revenue advanced to $11.6 million in Q1 2026, from $11.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $29.6 million in Q2 2025 and troughed at $9.6 million in Q1 2025.
  • A 4-year average of $13.1 million and a median of $11.1 million in 2023 frame the typical range for Current Deferred Revenue.
  • The largest YoY upside for Current Deferred Revenue was 162.99% in 2025 against a maximum downside of 32.92% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $11.1 million in 2023, then declined by 13.61% to $9.6 million in 2024, then rose by 13.89% to $11.0 million in 2025, then grew by 5.72% to $11.6 million in 2026.
  • Per Business Quant data, the three most recent Current Deferred Revenue figures were $11.6 million in Q1 2026, $11.0 million in Q4 2025, and $10.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.46 Mn
Mar 31, 2026 11.60 Mn
Dec 31, 2025 10.97 Mn
Sep 30, 2025 10.68 Mn
Jun 30, 2025 10.55 Mn
Mar 31, 2025 9.63 Mn
Dec 31, 2024 9.63 Mn
Sep 30, 2024 15.91 Mn
Jun 30, 2024 11.25 Mn
Mar 31, 2024 10.76 Mn
Dec 31, 2023 11.15 Mn
Sep 30, 2016 53,000.00
Jun 30, 2016 123,000.00
Mar 31, 2016 219,000.00
Dec 31, 2015 312,000.00
Sep 30, 2015 824,000.00
Jun 30, 2015 1.05 Mn
Mar 31, 2015 1.28 Mn
Dec 31, 2014 1.79 Mn
Sep 30, 2014 2.02 Mn